These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1942558)

  • 41. Treatment of 34 patients with myelodysplastic syndromes with 13-CIS retinoic acid.
    Bourantas KL; Tsiara S; Christou L
    Eur J Haematol; 1995 Oct; 55(4):235-9. PubMed ID: 7589340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hemolytic anemia complicated with Behçet's disease and myelodysplastic syndrome].
    Chyuma Y; Utsunomiya A; Saito T; Hanada S; Nishimata H; Arima T
    Rinsho Ketsueki; 1992 Mar; 33(3):333-7. PubMed ID: 1578637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of myelodysplastic syndrome with alfacalcidol].
    Tagawa M; Ito H; Kuriyama K; Tomonaga M; Ichimaru M
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3160-2. PubMed ID: 3674901
    [No Abstract]   [Full Text] [Related]  

  • 44. A randomized study of alfacalcidol in the refractory myelodysplastic anaemias. A Japanese cooperative study.
    Yoshida Y; Oguma S; Uchino H; Maekawa T; Nomura T
    Int J Clin Pharmacol Res; 1993; 13(1):21-7. PubMed ID: 8509233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radioimmunoassay for ubenimex in human serum.
    Koyama M; Watanabe N; Asakawa N
    J Pharm Biomed Anal; 1992; 10(2-3):137-40. PubMed ID: 1391092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of low-dose etoposide therapy for myelodysplastic syndromes.
    Ogata K; Nomura T
    Leuk Lymphoma; 1993 Dec; 12(1-2):35-9. PubMed ID: 8161935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of leukemia and myelodysplastic syndromes with orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine.
    Ohno R; Hirano M; Yamagata K; Ohara K; Shirakawa S; Hirota Y; Kobayashi M; Yoshikawa S; Mitomo Y; Ikeda Y
    Cancer Chemother Pharmacol; 1986; 17(2):161-4. PubMed ID: 3719896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis of p-hydroxyubenimex.
    Saino T; Seya K; Nishizawa R; Takita T; Aoyagi T; Umezawa H
    J Antibiot (Tokyo); 1987 Aug; 40(8):1165-9. PubMed ID: 3680027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ubenimex in the treatment of acute nonlymphocytic leukemia in adults.
    Urabe A; Mutoh Y; Mizoguchi H; Takaku F; Ogawa N
    Ann Hematol; 1993 Aug; 67(2):63-6. PubMed ID: 8347731
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A case-control study of myelodysplastic syndromes among Japanese men and women.
    Ido M; Nagata C; Kawakami N; Shimizu H; Yoshida Y; Nomura T; Mizoguchi H
    Leuk Res; 1996 Sep; 20(9):727-31. PubMed ID: 8947581
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical trials of bestatin for leukemia and solid tumors.
    Ota K; Uzuka Y
    Biotherapy; 1992; 4(3):205-14. PubMed ID: 1599804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Results of topotecan-based combination therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Beran M; Kantarjian H
    Semin Hematol; 1999 Oct; 36(4 Suppl 8):3-10. PubMed ID: 10622223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thalidomide in myelodysplastic syndromes.
    Zorat F; Pozzato G
    Biomed Pharmacother; 2002 Feb; 56(1):20-30. PubMed ID: 11905506
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of myelodysplastic syndromes with orally administered N-(2S, 3R)-3-amino-2-hydroxy-4-phenylbutyryl-L-leucine (ubenimex).
    Fukutani H; Naoe T; Saito H; Ohshima T; Omine M; Miura Y; Mizoguchi H; Kimura I; Tomonaga M; Ohno R
    Jpn J Clin Oncol; 1991 Aug; 21(4):287-92. PubMed ID: 1942558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetic and clinical pilot study of high-dose intermittent ubenimex treatment in patients with myelodysplastic syndrome.
    Ueda T; Tohyama K; Wano Y; Tsutani H; Fukushima T; Iwasaki H; Urasaki Y; Gotoh N; Kimura S; Okumura E
    Anticancer Res; 1994; 14(5B):2093-7. PubMed ID: 7840505
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topotecan in the treatment of hematologic malignancies.
    Beran M; Kantarjian H
    Semin Hematol; 1998 Jul; 35(3 Suppl 4):26-31. PubMed ID: 9779879
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.